Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
publishDate:"[2023 TO 2023]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=publishDate%3A%22%5B2023+TO+2023%5D%22&lookfor=%22COVID-19+infection%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=publishDate%3A%22%5B2023+TO+2023%5D%22&lookfor=%22COVID-19+infection%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=publishDate%3A%22%5B2023+TO+2023%5D%22&lookfor=%22COVID-19+infection%22&type=Subject
PubPharm (10)
1
A phase II study of a candidate COVID-19 vaccine in children (COV006) : A single-blind, randomised, phase II study to determine safety and immunogenicity of the Coronavirus Disease (COVID-19) vaccine ChAdOx1 in UK healthy children and adolescents (aged 6 - 17 years)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Comparing COVID-19 vaccine schedule combinations in adolescents (Com-COV3) : A single-blind, randomised, phase II UK multi-centre study to determine reactogenicity and immunogenicity of heterologous prime/boost COVID-19 vaccine schedules in adolescents
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A phase II study of a candidate COVID-19 vaccine in children (COV006) : A single-blind, randomised, phase II study to determine safety and immunogenicity of the Coronavirus Disease (COVID-19) vaccine ChAdOx1 in UK healthy children and adolescents (aged 6 - 17 years)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Comparing COVID-19 vaccine schedule combinations in adolescents (Com-COV3) : A single-blind, randomised, phase II UK multi-centre study to determine reactogenicity and immunogenicity of heterologous prime/boost COVID-19 vaccine schedules in adolescents
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial : A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial : A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19 – The EMPATHY” Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A study of the safety and efficacy of 7 days treatment with BIT225 in patients with COVID-19, compared to placebo, including measurement of antiviral activity, clinical recovery and immune biomarkers. : A Phase 2, Double Blind Placebo-Controlled Study of BIT225, an Orally Administered SARS-CoV-2 Viroporin Inhibitor, to Evaluate Antiviral Activity, Safety, and Immune Biomarkers in Non-Hospitalised Vaccinated and Unvaccinated Adults with COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A study of the safety and efficacy of 7 days treatment with BIT225 in patients with COVID-19, compared to placebo, including measurement of antiviral activity, clinical recovery and immune biomarkers. : A Phase 2, Double Blind Placebo-Controlled Study of BIT225, an Orally Administered SARS-CoV-2 Viroporin Inhibitor, to Evaluate Antiviral Activity, Safety, and Immune Biomarkers in Non-Hospitalised Vaccinated and Unvaccinated Adults with COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
COVID-19 vaccine boost to enhance immunity (The Booster Study) : COVID-19 vaccine boost to enhance immunity in healthy adults aged 18-65 (The Booster Study)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
COVID-19 vaccine boost to enhance immunity (The Booster Study) : COVID-19 vaccine boost to enhance immunity in healthy adults aged 18-65 (The Booster Study)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Erscheinungsjahr: 2023-2023
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
10
WHO International Clinical Trials Registry Plat...
Thema
10
610
Phase: Phase 2
10
Study Type: Interventional
4
Recruitment Status: Recruiting
2
Medical Condition: Ambulatory Symptomatic COVID...
2
Medical Condition: COVID-19; COVID-19;Infection...
2
Medical Condition: COVID-19; COVID-19;Infection...
2
Medical Condition: Prevention of COVID-19 infec...
2
Medical Condition: Prevention of COVID-19 infec...
2
Recruitment Status: Active, not recruiting
2
Recruitment Status: Not yet recruiting
2
Recruitment Status: Other
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2023-2023
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...